Recombinant Smoothelin Antibody / SMSMO / SMTN, Clone: [SMTN/2320R], Rabbit, Monoclonal

Artikelnummer: NSJ-V4050SAF-100UG
Artikelname: Recombinant Smoothelin Antibody / SMSMO / SMTN, Clone: [SMTN/2320R], Rabbit, Monoclonal
Artikelnummer: NSJ-V4050SAF-100UG
Hersteller Artikelnummer: V4050SAF-100UG
Alternativnummer: NSJ-V4050SAF-100UG
Hersteller: NSJ Bioreagents
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IHC-P
Spezies Reaktivität: Human
Immunogen: Recombinant full-length human protein was used as the immunogen for the recombinant Smoothelin antibody.
Smoothelin is found exclusively in contractile smooth muscle cells. It associates with stress fibers and constitutes part of the cytoskeleton. In the vascular system, smoothelin expression is limited to large veins and arteries capable of pulsatile contraction. As a marker for the highly differentiated contractile smooth muscle cell, smoothelin expression is useful for studying vascular malformation and injury. It is a constituent of the smooth muscle cell cytoskeleton protein exclusively found in differentiated smooth muscle cells (SMC). Cells with SMC-like characteristics, such as myofibroblasts and myoepithelial cells, as well as skeletal and cardiac muscle do not contain smoothelin.To distinguish bladder muscularis mucosae (MM) from muscularis propria (MP) muscle bundles is crucial for accurate staging of bladder carcinoma. Strong smoothelin expression is nearly exclusively observed in muscularis propria. Therefore, the staining pattern of MP (strongly positive) and MM (negative or weakly positive) makes this antibody an attractive diagnostic tool. Anti-smoothelin immunostaining can be helpful in differentiating benign (+) from malignant smooth muscle tumors (-), and other mimics (-).
Klonalität: Monoclonal
Klon-Bezeichnung: [SMTN/2320R]
UniProt: P53814
Reinheit: Protein A/G affinity
Formulierung: 1 mg/ml in 1X PBS, BSA free, sodium azide free
Antibody Type: Primary Antibody
Application Verdünnung: Immunohistochemistry (FFPE): 1-2ug/ml
Anwendungsbeschreibung: Optimal dilution of the recombinant Smoothelin antibody should be determined by the researcher.